Literature DB >> 8749626

Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

J Romero-Vivas1, M Rubio, C Fernandez, J J Picazo.   

Abstract

We prospectively studied all cases of Staphylococcus aureus bacteremia that occurred during an extensive outbreak of methicillin-resistant S. aureus (MRSA) in our hospital over a 4-year period (January 1990 through September 1993). We report the results of a comparative analysis of the clinical characteristics and mortality rates among patients with nosocomial bacteremia caused by MRSA (84 cases) or methicillin-susceptible S. aureus (MSSA; 100 cases). The patients with MRSA bacteremia were older than those with MSSA bacteremia (69 years vs. 54 years, respectively; P < .01) and were more likely than those with MSSA bacteremia to have the following predisposing factors: a prolonged hospitalization (32 days vs. 14 days, respectively; P < .01); prior antimicrobial therapy (61% vs. 34%, respectively; P < .01); urinary catheterization (58% vs. 27%, respectively; P < .01); nasogastric tube placement (31% vs. 13%, respectively; P < .01); and prior surgery (45% vs. 31%, respectively; P = .05). Multivariate analysis with use of the stepwise logistic regression method showed a relationship between mortality and the following variables: methicillin resistance (odds ratio [OR], 3), meningitis (OR, 13), and inadequate treatment (OR, 11).

Entities:  

Mesh:

Year:  1995        PMID: 8749626     DOI: 10.1093/clinids/21.6.1417

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Stopping short the spread of methicillin-resistant Staphylococcus aureus.

Authors:  J Verhoef
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

2.  Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients.

Authors:  G J Murphy; R Pararajasingam; A Nasim; M J Dennis; R D Sayers
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

3.  Clinical impact of a PCR assay for identification of Staphylococcus aureus and determination of methicillin resistance directly from blood cultures.

Authors:  M Hallin; N Maes; B Byl; F Jacobs; Y De Gheldre; M J Struelens
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres.

Authors:  John M Conly; H Grant Stiver; Karl A Weiss; Debbie L Becker; Andrew J Rosner; Elizabeth Miller
Journal:  Can J Infect Dis       Date:  2003-11

5.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

6.  Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; J Schulze; K P Hunfeld; V Schäfer; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

7.  Changes in the agr locus affect enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  Yoichi Sugiyama; Kazuya Okii; Yoshiaki Murakami; Takashi Yokoyama; Yoshio Takesue; Hiroki Ohge; Taijiro Sueda; Eiso Hiyama
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia.

Authors:  Tariq A Madani
Journal:  Can J Infect Dis       Date:  2002-07

9.  The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Authors:  Andrew E Simor; Mark Loeb
Journal:  Can J Infect Dis       Date:  2004-01

10.  The costs and consequences of methicillin-resistant Staphylococcus aureus infection treatments in Canada.

Authors:  Andrew J Rosner; Debbie L Becker; Angelina H Wong; Elizabeth Miller; John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.